Is antithrombotic prophylaxis required in cancer patients with central venous catheters? Yes for special patient groups.
Huisman
M V
MV
Department of General Internal Medicine, LUMC, Leiden, The Netherlands. m.v.huisman@lumc.nl
D002405:Catheterization, Central Venous / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D005343:Fibrinolytic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D017410:Practice Guidelines as Topic; D011292:Premedication / Q000009:adverse effects*; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control*; D016896:Treatment Outcome
D005343:Fibrinolytic Agents